Form 4 for TMO Thermo Fisher Scientific
Accepted 2026-09-01 16:11:10 ET · period of report 2026-08-28 · accession 0000097745-26-000166 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-09-01 16:11 | 2026-08-28 | TMO | Meyer James | CFO, Sr. VP | F - Tax | $622.18 | -270.28 | 5,560 | -5% | -$168.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-28 | F | D | 37.23 | $622.18 | 5,792.81 | D | — | — | |
| 2 | Common | Common Stock | 2026-08-28 | F | D | 44.48 | $622.18 | 5,748.32 | D | — | — | |
| 3 | Common | Common Stock | 2026-08-28 | F | D | 19.82 | $622.18 | 5,728.50 | D | — | — | |
| 4 | Common | Common Stock | 2026-08-28 | F | D | 55.12 | $622.18 | 5,673.38 | D | — | — | |
| 5 | Common | Common Stock | 2026-08-28 | F | D | 113.62 | $622.18 | 5,559.76 | D | — | — |